Research and Development (R&D) Expenses: R&D expenses were $10.7 million for the third quarter of 2025, compared to $14.1 million for the same period in 2024. General and Administrative (G&A) Expenses ...
Boundless Bio Inc. (($BOLD)) announced an update on their ongoing clinical study. Boundless Bio Inc. (BOLD) is conducting a clinical study titled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback